(Q44225211)

1 December 2017

Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine (English)

1 reference

1 December 2017

Qin Zhao

1

1 reference

PubMed ID

12445575

1 December 2017

Xi Can Tang

series ordinal

2

1 reference

PubMed ID

12445575

1 December 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

European Journal of Pharmacology

1 December 2017

1 reference

1 December 2017

455

1 reference

1 December 2017

2-3

1 reference

1 December 2017

101-107

1 reference

The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

The cholinergic hypothesis of geriatric memory dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Asymmetric and globular forms of acetylcholinesterase in mammals and birds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Molecular forms of acetylcholinesterase in brain, nerve and muscle: Nature, localization and dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Profile of acetylcholinesterase in brain areas of male and female rats of adult and old age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

A new and rapid colorimetric determination of acetylcholinesterase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Molecular forms of acetylcholinesterase in bovine caudate nucleus and superior cervical ganglion: solubility properties and hydrophobic character

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Striatal interneurones: chemical, physiological and morphological characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

The Molecular Forms of Cholinesterase and Acetylcholinesterase in Vertebrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Differential inhibition of acetylcholinesterase molecular forms in normal and Alzheimer disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Amphiphilic and hydrophilic forms of acetyl- and butyrylcholinesterase in human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Phenylmethylsulfonyl fluoride inhibitory effects on acetylcholinesterase of brain and muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Huperzine A: A novel acetylcholinesterase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

The cholinesterases: from genes to proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

Active-site catalytic efficiency of acetylcholinesterase molecular forms in Electrophorus, torpedo, rat and chicken

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902589-X

10.1016/S0014-2999(02)02589-X

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12445575